Global health is entering a critical reset as India expands digital mental health support, launches high-altitude medical research, and Roche calls for a healthcare overhaul to tackle the growing burden of non-communicable diseases.
It is past 11 pm. Your day's work is done, dinner is over and there is little left to do. Yet the phone is still in your hand. One last email turns into a scroll through social media, followed by a few videos and messages.
Uttar Pradesh's single-dose iron injection during pregnancy program aims to improve maternal anaemia treatment by reducing repeat visits and expanding access to intravenous iron.
India’s pharma regulatory landscape is expanding beyond manufacturing compliance, with new developments targeting medicine pricing, sterile-drug quality, medical marketing, and obesity treatment.
The FDA’s latest actions bring new hope for cancer and herpes treatment while product recalls raise fresh concerns about drug safety and quality.
The Thyrocare Madurai lab strengthens regional healthcare infrastructure by expanding access to routine and specialised diagnostic testing across southern Tamil Nadu.
The most popular schizophrenia pill gets a once-a-month shot as Teva wins FDA approval for its WELTRUZA injection.
Dr Reddy's received two USFDA observations at its Andhra Pradesh facility, highlighting the importance of Indian pharma GMP compliance and manufacturing quality.
NVIDIA-backed AI is powering Iambic Therapeutics’ cancer drug pipeline as the biotech prepares for an IPO targeting a valuation of USD 806 million.
Health Minister J.P. Nadda has launched JOSH Teams to boost TB elimination in India, putting fresh focus on drug demand, supply and access.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
